| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
|
N Engl J Med
|
2009
|
5.79
|
|
2
|
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
|
Clin Cancer Res
|
2008
|
2.06
|
|
3
|
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
|
Lab Invest
|
2004
|
2.05
|
|
4
|
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
|
Cancer Res
|
2007
|
1.96
|
|
5
|
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.
|
Cancer Res
|
2004
|
1.90
|
|
6
|
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.
|
Proc Natl Acad Sci U S A
|
2010
|
1.67
|
|
7
|
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
|
Clin Cancer Res
|
2008
|
1.66
|
|
8
|
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
|
Clin Cancer Res
|
2008
|
1.54
|
|
9
|
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.
|
Proc Natl Acad Sci U S A
|
2007
|
1.53
|
|
10
|
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
|
Cancer Res
|
2003
|
1.40
|
|
11
|
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
|
BMC Genomics
|
2007
|
1.24
|
|
12
|
Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.
|
Cancer Res
|
2008
|
1.23
|
|
13
|
p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases.
|
Clin Exp Metastasis
|
2004
|
1.17
|
|
14
|
High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
|
Clin Cancer Res
|
2007
|
1.12
|
|
15
|
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
|
Int J Cancer
|
2008
|
1.11
|
|
16
|
Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
|
Lab Invest
|
2002
|
1.08
|
|
17
|
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors.
|
J Clin Oncol
|
2005
|
1.07
|
|
18
|
Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.
|
Int J Cancer
|
2006
|
1.05
|
|
19
|
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
|
BMC Cancer
|
2007
|
1.04
|
|
20
|
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
|
J Transl Med
|
2013
|
1.02
|
|
21
|
High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.
|
J Pathol
|
2005
|
1.00
|
|
22
|
Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia.
|
Gynecol Oncol
|
2004
|
0.99
|
|
23
|
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.
|
Mod Pathol
|
2008
|
0.97
|
|
24
|
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.
|
Cancer Immunol Immunother
|
2012
|
0.97
|
|
25
|
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.
|
Int J Cancer
|
2006
|
0.94
|
|
26
|
Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands.
|
Gynecol Oncol
|
2004
|
0.94
|
|
27
|
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
|
Cancer Res
|
2004
|
0.93
|
|
28
|
EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
|
Int J Cancer
|
2006
|
0.92
|
|
29
|
Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.
|
Am J Pathol
|
2003
|
0.91
|
|
30
|
Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer.
|
Mod Pathol
|
2011
|
0.91
|
|
31
|
Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
|
Int J Cancer
|
2004
|
0.91
|
|
32
|
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.
|
Cancer Immunol Immunother
|
2013
|
0.89
|
|
33
|
Frequent HLA class I loss is an early event in cervical carcinogenesis.
|
Hum Immunol
|
2006
|
0.88
|
|
34
|
The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
|
Lab Invest
|
2002
|
0.88
|
|
35
|
Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations.
|
Cell Oncol (Dordr)
|
2011
|
0.87
|
|
36
|
Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
|
Carcinogenesis
|
2005
|
0.87
|
|
37
|
Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
|
Eur J Immunol
|
2002
|
0.86
|
|
38
|
Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
|
Cancer Genet Cytogenet
|
2004
|
0.86
|
|
39
|
Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
|
Cancer
|
2007
|
0.86
|
|
40
|
HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.
|
J Transl Med
|
2012
|
0.85
|
|
41
|
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
|
Int J Cancer
|
2008
|
0.85
|
|
42
|
Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases model.
|
Cancer Res
|
2004
|
0.85
|
|
43
|
FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.
|
Cancer Immunol Immunother
|
2015
|
0.85
|
|
44
|
Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells.
|
Cancer Genet Cytogenet
|
2007
|
0.83
|
|
45
|
Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma.
|
Gynecol Oncol
|
2007
|
0.83
|
|
46
|
Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries.
|
Int J Cancer
|
2005
|
0.81
|
|
47
|
Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.
|
Int J Cancer
|
2014
|
0.81
|
|
48
|
A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.
|
Cancer Immunol Immunother
|
2003
|
0.80
|
|
49
|
Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia.
|
Int J Cancer
|
2014
|
0.80
|
|
50
|
Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry.
|
J Immunol Methods
|
2002
|
0.78
|
|
51
|
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
|
Int J Cancer
|
2007
|
0.77
|
|
52
|
Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
|
Mol Med Rep
|
2011
|
0.76
|
|
53
|
Cytomorphological analysis of uterine cervical pap smears in relation to human papillomavirus infection in Indonesian women.
|
Acta Cytol
|
2012
|
0.75
|
|
54
|
Ethnic patterns of cytologic abnormalities in cervical smears in suriname, a high-risk area for cervical cancer.
|
Acta Cytol
|
2006
|
0.75
|
|
55
|
Reasons for early interventions by gynaecologists in a clinical follow-up study on cervical intraepithelial neoplasia.
|
Eur J Obstet Gynecol Reprod Biol
|
2006
|
0.75
|
|
56
|
Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours.
|
Eur J Hum Genet
|
2008
|
0.75
|
|
57
|
Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
|
Mol Immunol
|
2007
|
0.75
|